Canada's drug pricing plan prompts backlash

The final version of guidelines issued by Canada’s federal drug price regulator last week has caused uproar among the pharma industry.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Pricing, patents and the PMPRB in Canada

14 December 2020 Micheline Gravelle and Iris Cheung of Bereskin & Parr provide an update on the final version of guidelines issued by Canada’s federal drug price regulator—and its likely implications.

Americas

Pharma industry challenges Canada’s drug pricing plan

9 September 2019 Innovative Medicines Canada, an association that represents drugmakers in Canada, has challenged the overhaul of Canada’s drug-pricing regime.

Big Pharma

Canada authorises compulsory licences for COVID-19 shortfalls

27 March 2020 Canada is the latest country to adopt emergency measures in order to secure drugs and medical equipment in the fight against COVID-19.

More on this story

Big Pharma

Pricing, patents and the PMPRB in Canada

Americas

Pharma industry challenges Canada’s drug pricing plan

9 September 2019 Innovative Medicines Canada, an association that represents drugmakers in Canada, has challenged the overhaul of Canada’s drug-pricing regime.

Big Pharma

Canada authorises compulsory licences for COVID-19 shortfalls

27 March 2020 Canada is the latest country to adopt emergency measures in order to secure drugs and medical equipment in the fight against COVID-19.

More on this story

Big Pharma

Pricing, patents and the PMPRB in Canada

Americas

Pharma industry challenges Canada’s drug pricing plan

9 September 2019 Innovative Medicines Canada, an association that represents drugmakers in Canada, has challenged the overhaul of Canada’s drug-pricing regime.

Big Pharma

Canada authorises compulsory licences for COVID-19 shortfalls

27 March 2020 Canada is the latest country to adopt emergency measures in order to secure drugs and medical equipment in the fight against COVID-19.